Advertisement

Loading...

Xylo Technologies Ltd.

XYLONASDAQ
Healthcare
Medical - Devices
$5.07
$0.00(0.00%)
U.S. Market opens in 17h 10m

Xylo Technologies Ltd. Fundamental Analysis

Xylo Technologies Ltd. (XYLO) shows moderate financial fundamentals with a PE ratio of 1.83, profit margin of 20.27%, and ROE of 11.90%. The company generates $0.0B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

Cash Position374.12%
PEG Ratio0.04

Areas of Concern

Operating Margin0.40%
We analyze XYLO's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 57.1/100 based on profitability, valuation, growth, and balance sheet metrics. The C grade reflects average fundamentals, with notable risks in certain areas.

Fundamental Health Score

C
57.1/100

We analyze XYLO's fundamental strength across five key dimensions:

Efficiency Score

Weak

XYLO struggles to generate sufficient returns from assets.

ROA > 10%
5.70%

Valuation Score

Excellent

XYLO trades at attractive valuation levels.

PE < 25
1.83
PEG Ratio < 2
0.04

Growth Score

Weak

XYLO faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Excellent

XYLO maintains a strong and stable balance sheet.

Debt/Equity < 1
0.38
Current Ratio > 1
1.14

Profitability Score

Weak

XYLO struggles to sustain strong margins.

ROE > 15%
11.90%
Net Margin ≥ 15%
20.27%
Positive Free Cash Flow
No

Key Financial Metrics

Is XYLO Expensive or Cheap?

P/E Ratio

XYLO trades at 1.83 times earnings. This suggests potential undervaluation.

1.83

PEG Ratio

When adjusting for growth, XYLO's PEG of 0.04 indicates potential undervaluation.

0.04

Price to Book

The market values Xylo Technologies Ltd. at 0.22 times its book value. This may indicate undervaluation.

0.22

EV/EBITDA

Enterprise value stands at -1.49 times EBITDA. This is generally considered low.

-1.49

How Well Does XYLO Make Money?

Net Profit Margin

For every $100 in sales, Xylo Technologies Ltd. keeps $20.27 as profit after all expenses.

20.27%

Operating Margin

Core operations generate 0.40 in profit for every $100 in revenue, before interest and taxes.

0.40%

ROE

Management delivers $11.90 in profit for every $100 of shareholder equity.

11.90%

ROA

Xylo Technologies Ltd. generates $5.70 in profit for every $100 in assets, demonstrating efficient asset deployment.

5.70%

Following the Money - Real Cash Generation

Operating Cash Flow

Xylo Technologies Ltd. generates limited operating cash flow of $-1.52M, signaling weaker underlying cash strength.

$-1.52M

Free Cash Flow

Xylo Technologies Ltd. generates weak or negative free cash flow of $-1.53M, restricting financial flexibility.

$-1.53M

FCF Per Share

Each share generates $-2.05 in free cash annually.

$-2.05

FCF Yield

XYLO converts -42.10% of its market value into free cash.

-42.10%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

1.83

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

0.04

vs 25 benchmark

P/B Ratio

Price to book value ratio

0.22

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.36

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.38

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.14

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.12

vs 25 benchmark

ROA

Return on assets percentage

0.06

vs 25 benchmark

ROCE

Return on capital employed

0.002

vs 25 benchmark

How XYLO Stacks Against Its Sector Peers

MetricXYLO ValueSector AveragePerformance
P/E Ratio1.8327.91 Better (Cheaper)
ROE11.90%687.00% Weak
Net Margin20.27%-45285.00% (disorted) Strong
Debt/Equity0.380.33 Neutral
Current Ratio1.142795.76 Neutral
ROA5.70%-13557.00% (disorted) Weak

XYLO outperforms its industry in 2 out of 6 key metrics, particularly excelling in Net Margin, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Xylo Technologies Ltd.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ